A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
A phase 2 trial of Farletuzumab-exatecan, Bevacizumab, Carboplatin in ovarian cancer, run by CSPC Megalith Biopharmaceutical Co.,Ltd., now recruiting.
Overview
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer is a phase 2 interventional study registered as NCT07714668 by CSPC Megalith Biopharmaceutical Co.,Ltd., with 171 participants planned, started 2026-08-13 and due to reach its primary completion in 2028-04-30. Interventions recorded: SYS6041, bevacizumab, SYS6041, carboplatin, bevacizumab, paclitaxel, carboplatin, bevacizumab, SYS6041, enlonstobart, bevacizumab. Conditions listed: Ovarian Cancer, Recurrent Ovarian Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors
- TrialOregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialPhase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ov
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialStudy to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialA Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialA Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialA Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.